Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1529 - 1539
Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.
ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1540 - 1550
Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
Marcovecchio ML. et al, (2018), DIABETES CARE, 41, 1963 - 1969
Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks-Reply.
Clarke RJ. et al, (2018), JAMA Cardiol
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-Analysis.
Beveridge LA. et al, (2018), J Am Heart Assoc, 7
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
Berlanga-Taylor AJ. et al, (2018), EBioMedicine, 31, 133 - 142
Ezetimibe: Likely to Be Beneficial For All.
Herrington WG. et al, (2018), Circulation, 137, 1583 - 1584
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Aung T. et al, (2018), JAMA Cardiol, 3, 225 - 234
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
Aung T. et al, (2018), JAMA Cardiol, 3, 225 - 234
Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.
Parish S. et al, (2018), Circ Genom Precis Med, 11
The Role of Emerging Risk Factors in Cardiovascular Outcomes.
Lacey B. et al, (2017), Curr Atheroscler Rep, 19
LENS - a clinical trial embedded in routine clinical practice to reduce the burden of diabetic eye disease
Preiss D. et al, (2017), TRIALS, 18
Using optical character recognition for processing paper forms in a large randomised clinical trial
Murawska A. et al, (2017), TRIALS, 18
Telephone support for mail based recruitment and follow-up in a large randomized trial
Chen F. et al, (2017), TRIALS, 18
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)-A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics.
REVEAL Collaborative Group None. et al, (2017), Am Heart J, 187, 182 - 190
Optimum dose of vitamin D for disease prevention in older people: BEST-D trial of vitamin D in primary care.
Hin H. et al, (2017), Osteoporos Int, 28, 841 - 851